Rivaroxaban, a direct factor Xa inhibitor, attenuates neointima formation following vascular injury in the mouse through the inhibition of proliferative activation of vascular smooth muscle cells.
Rivaroxaban, a direct factor Xa inhibitor, attenuates neointima formation following vascular injury in the mouse through the inhibition of proliferative activation of vascular smooth muscle cells.
复制标题
Rivaroxaban 是一种直接 Xa 因子抑制剂，通过抑制血管平滑肌细胞的增殖活化来减弱小鼠血管损伤后的新内膜形成。
DOI：
--
复制
发表时间：
2014
期刊：
影响因子：
--
通讯作者：
Masataka Sata.
中科院分区：
文献类型：
--
作者：
Tomoya Hara;Daiju Fukuda;Kimie Tanaka;Yasutomi Higashikuni;Yoichiro Hirata;Hirotsugu Yamada;Takeshi Soeki;Tetsuzo Wakatsuki;Michio Shimabukuro;Masataka Sata.
